Search

everythinglearnresearchcommunity

for

Search:↓

Beard hair transplantation is generally satisfying, requires 250-800 grafts, uses FUE to avoid scars, needs careful planning, has some risks, and hair regrowth starts after 4-6 months.

Hair loss in both Androgenetic Alopecia and Alopecia Areata is often accompanied by inflammation around hair follicles, but the location and severity of this inflammation varies.

The document explains how hair follicles develop, their structure, and how they grow.

The book is a detailed guide on hair and scalp diseases, useful for dermatopathologists.

Robotic hair transplantation with AI offers more reliable, precise, and efficient hair restoration.

The document concludes that hair transplant clinics should focus on effective marketing, online presence, and quality patient care, while the industry should promote high standards and education through organizations like FUE Europe.

To prevent thinning in the donor area, harvest less than 50% of the original hair density in repeat hair transplants.

Hidradenitis Suppurativa is likely an autoinflammatory disease, and better understanding its causes could improve treatments.

Hair restoration techniques have improved over time, focusing on better results and less scarring, but skilled doctors are essential for natural-looking outcomes.

Male-pattern hair loss is normal, often involves hormone effects on hair follicles, and can be treated with medication or surgery, but new treatments are being researched.

Using platelet-rich plasma in hair restoration surgery significantly improves hair density after 6 months and is safe to use.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

Researchers developed a nanomedicine for acne treatment that delivers medication with less irritation and is non-irritating for oily skin.

Cicatricial pattern hair loss is likely advanced common baldness, not a type of lichen planopilaris.

Testosterone helps beard and axillary hair cells grow by releasing growth factors from dermal papilla cells.

Some chemicals and drugs can cause hair loss, which usually grows back after stopping the treatment.

Topical minoxidil does not change the activity of hair follicle enzymes that metabolize it.

Hair greying is linked to reduced ATM protein in hair cells, which protects against stress and damage.

Nanoparticles may improve caffeine delivery for hair growth, offering a potential alternative to minoxidil for hair loss treatment.

Accurate clinical, histological, and genetic methods are key for understanding and treating hair disorders.

The document corrects a name misspelling, acknowledges a pioneer in hair transplantation, and notes a missing conflict of interest disclosure.

Scientists created tiny particles loaded with a hair growth drug, minoxidil, that specifically target hair follicles and skin cells to potentially improve hair growth.

The International Society of Hair Restoration Surgery recommends that hair restoration surgeons should be skilled in diagnosing and treating hair loss, ensuring patient safety, optimizing aesthetic results, and managing complications.

Hair loss requires customized treatments based on its various causes and types.

The new FUE device improves hair transplant safety and efficiency.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

Hypothyroidism patients with hair loss typically have thinning hair, smaller hair follicles, and normal hair shedding.

Newer contraceptives with less androgenic progestins may reduce female hair loss.

Botulinum toxin injections may help treat hair loss by blocking harmful secretion in hair follicles.

The document concludes that using autologous follicular unit implantation is a successful method to correct hairline deformities after facial rejuvenation.